Psychopathology following epilepsy neurosurgery is a significant risk. Treatment modalities have not been addressed in the literature. As disproportionately elevated suicide rates have been reported, it is critical to treat aggressively any psychiatric illness wherein suicidal ideation is a key component. This case reports the safe utilization of electroconvulsive therapy (ECT) for intractable depression following epilepsy neurosurgery (24 references).
INTRODUCTION

Surgical intervention
for medically intractable epilepsy is ,a recognized treatment'.
Approximately 80% of these surgeries result in total remission or marked reduction in seizure frequency*. In the face of such positive results, patient dissatisfaction is most often related to postoperative neurological, cognitive, psychiatric and psychosocial deficits*. En bloc temporal lobectomy (TL) has been the standard surgical approach for patients with a temporal lobe focus3. More recently, selective amygdalohippocampectomy (AHE) has been found to have similar surgical success4. Further, AHE has decreased neuropsychologic complication?' when compared to TL. In one series, TL resulted in a 35% prevalence of psychiatric features during an eight-year follow-up with predominantly post- operative affective disorde?. In a smaller series with shorter follow-up, AHE resulted in 8% de nouo affective disorders". Postoperative de nouo psychoses have also been reported"'. Thus, the true surgical outcome is a combination of decreased seizures with minimal psychiatric, neurological, neuropsychological, and psychosocial complications. When psychiatric features are present, it is important that the intervention does not compound potential surgical morbidity or result in increased seizures.
This case represents the only known treatment with electroconvulsive therapy (ECT) for intractable depression following AHE.
CASE REPORT
This 26 year old white single female presented to a major medical centre with uncontrolled complex partial seizures of 22 years duration. The patient was not responsive to phenobarbital, phenytoin, valproic acid or carbamazepine. Phase I and II evaluations confirmed focal seizure onset within the right mesial temporal lobe, though an MRI had identified a nonepileptogenic left insular cavernous angioma. A selective right AHE was performed with total seizure control now greater than 40 months exluding one seizure while on desipramine.
The patient when fifteen sought counselling for inability to communicate with her parents and difficuity coping with epilepsy. Otherwise, the patient had a good premorbid psychiatric history. Within three weeks of surgery, the patient developed a severe de nduo major depression" characterized by decreased appetite with weight loss, decreased energy, irregular sleep, decreased interests, self-deprecatory thoughts, social withdrawal but no suicidal ideation. During the ensuing year, the patient underwent a series of antidepressant trials including the following psychotropics: nortriptyline, fluoxetine, trazodone, bupropion, lithium (used for synergism), desipramine, doxepin, sertraline, paroxetine, amitriptyline, and methylphenidate.
An unremitting vegetative-affective cluster with suicidal ideation/intent/plan necessitated the urgent hospitalization during which the patient received ECT. The pre-ECT evaluation included normal standard chemistries, CXR, spine series, and EKG. Pre-ECT EEG revealed right temporal delta focus. Pre-ECT SPECT demonstrated right temporal perfusion deficit consistent with AHE. Neuropsychology, neurology, neurosurgery, ECT indications, and ECT competency consultations were performed. This physician reviewed the alternatives, benefits, and risks of ECT as outlined in the California Uniform Informed Consent for ECT with the patient and family12. Special circumstances discussed included: potential increased confusion to the point of delirium, increased memory loss to the point of global amnesia, status epifepticus'3, and recurrence of seizures secondary to kindling.
The patient underwent a course of 15 ECT treatments utilizing the MECTA-SRl. Power settings were pulse width 1.6-1.8 ms/frequency 70 hz/duration 2.0 s/current 0.7 amp. The second to fourth treatments were right unilateral; all other treatments were bilateral. Total seizure duration from these treatments equaled 535 s. Premeditations were 100 mg methohexital and 80 mg succinylcholine. Following the first ECT, rhythmic left hand movement was noted which responded to 3 mg midazolam.
Portable 18 channel EEG utilizing the lo-20 electrode placement systemI revealed the original right temporal delta focus only. Thereafter, each ECT was monitored with 18 channel EEG 2 minutes before, during and for 18 minutes following the treatment.
Similar hand movements occurred after the sixth treatment which responded to 3 mg midazolam;
however, no neurophysiological correlates were noted. At that juncture, further neurology, neuropsychology, neurosurgery, and external ECT expert consulations occurred. The neurosurgeon was concerned with the risk of producing a kindling effect were further ECT to occur. The neurologist cleared the patient after repeat SPECT was unchanged and an MRI revealed abnormalities consistent with AHE. The ECT consultant strongly recommended a minimum of 15 bilateral ECT. The remaining treatments were uneventful.
Neuropsychometrics were performed presurgery, pre-ECT, throughout the ECT course, and serially thereafter. Those tests most sensitive to the learning test-retest phenomenon were alternated.
Brief descriptions of those tests reported in this paper are included in the Index'5,'6. The data from these tests are summarized in Tables 1-4 .
After the completion of ECT, acute suicidal intent remitted to be repIaced with chronic suicidal ideation without active intent or plan. Unfortunately, depressive symptoms with reduced severity also persisted. Further psychotropics and medications known to have positive affective effects were utilized including: phenelzinc, imipramine, buspirone, pemoline, bromocriptine, clomipramine, protriptyline, venlafaxine, amoxapine, nefazadone, felbamate, gabapentin, and risperidone. For the past year increasing suicidal ideation with intent and severity of vegetative-affective cluster have returned. At one point the worsening neuropsychometrics led to a PET scan which was consistent with the original surgery but without any structural/functional changes. ECT has again been considered to break the acute suicidal intent.
DISCUSSION
This is a unique case study with obvious design limitations. Specifically, not all neuropsychological tests done pre-surgery were identical to pre-ECT, during the ECT series itself, or post ECT. As a clinical case in progress, basic neuropsychometrics were carried out pre-ECT. Whenever possible, alternative forms of sensitive tests were utilized to minimize the learning test-retest phenomenon.
In toto, the patient received 19 neuropsychological measures plus subtests in addition to psychodiagnostics. In retrospect, frontal measures not included in the original pre-surgery battery should be mandatory as should the Hamilton Depression Scale or the Beck Depression Inventory. The authors selected 9 of 14 key data points to report in this case study; with a rigorous prospective study the other points would have more meaning. From the initiation of Phase I, specific measures should be monitored at specific intervals. During ECT, such monitoring should be more frequent; however, the clinician must appreciate the interactive effects of improving affective state with ECT induced cognitive deficits.
Memory, executive function, and motor performance were relatively unaffected by the first to fifth ECT treatments when compared to baseline scores. One negative exception was verbal fluency (Controlled Oral Word Association Test) which declined from 43 to 15%. Positive exceptions included the Rey Auditory Verbal Learning Test (RAVLT) wherein total recall improved from 3 to 44%, and the Auditory Consonant Trigrams (ACT) 36 second delay recall which improved from 2 to 90%. Notable decline in verbal Recovery from anterograde amnesia is thought to be considerable at one month post-ECT and substantial between three and nine months post-ECT". In this case study, one year post-ECT performances revealed mixed findings. Logical Memory (paragraph recall) was similar to presurgery memory recall, while RAVLT measures of total recall, retention, and delayed recall had declined and remained impaired. Only recognition memory had returned to normal. With regard to visual memory, delayed recall of a The one year neuropsychometric declines led to a PET scan which ruled out any new or recurrent process. The decline and persistence of deficits were attributed to increasing depression and possible motivational issues. The patient has now been followed through the second post-ECT year with severe, chronic depression continuing to dampen neuropsychological functioning in selected areas (memory, frontal system measures, and motor speed) while leaving other areas intact (visuospatial and visuomotor performances). ECT has carried the unwarranted reputation of causing permanent brain damage. Though spotty memory loss can last for years, most memory measures improve with ECT or after a sufficient time period post-ECT",".
The pervasive neuropsychometric deficits noted two years post-ECT are considered part of this patient's depressive constellation.
Literature review does not substantiate ECT-induced structural changes or neuronal cell loss". The neurosurgeon's concern with potential kindling after the sixth ECT was unfounded. Research supports the inhibition of amygdala kindling with ECT'". ECT can be used as an adjunctive anticonvulsant2"'2.
The only seizure this patient had post-surgery was on the antidepressant desipramine; no seizures have occurred in the two years post-ECT. The theory of forced normalization23 led the external ECT consultant to recommend the extended series of bilateral treatments. Affective disorders post AHE/TL are multifactorial (including organic, Controlled Oral Word Association Test requires the examinee to produce as many words beginning with a particular letter in 1 minute (3 different letters are given). The ability to initiate, maintain set, and shift (to a new letter) is assessed. This is a measure of verbal fluency.
MOTOR TESTS
Tests in this area measure motor speed and/or manual dexterity. Impairments can suggest lateralized or bilateral frontal motor dysfunction. Certain psychiatric states, especially depression, and peripheral motor problems can also be contributory.
Finger Tapping Test measures tapping speed of the index finger of each hand.
Grooved Pegboard Test measures finger (manual) dexterity and speed. Difficulties with the spatial component of this test may also suggest parietal lobe dysfunction.
WECHSLER
ADULT INTELLIGENCE SCALE-REVISED Digit Span requires recitation of an increasing string of numbers in a forward and backward fashion. It assesses immediate auditory attention and for Digits backward requires an ability to hold information in short-term memory while processing it in the reverse order.
Digit Symbol requires rapid associative learning and is multimodal in nature with motor speed, memory, and visuomotor coordination involved in task execution.
Block Design involves manipulation of blocks in order to match a particular design. Visuospatial analysis, synthesis, and visuomotor (constructional) abilities are necessary.
